Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Disease-modifying Therapy Discontinuation and Outcomes of Older People with Multiple Sclerosis (MS) at a Large Academic MS Center in Toronto, Canada

              Author:Tsai, Chia-Chen   Raufdeen, Fasna   Schneider, Raphael   Marriott, James   Oh, Jiwon   

              Session Name:S3: Multiple Sclerosis: Clinical Trials  

              Topic:Multiple Sclerosis  

              Program Number:S3.005  

              Author Institution:University of British Columbia, Vancouver, BC, Canada  University of Toronto, Toronto, ON, Canada  

              Cognitive Trajectories 1 Year Before and After COVID-19 in an Early-Treated HIV Cohort

              Author:Ocampo, Ferron   Hamby, Tyler   Poonpitak, Luxe-naree   Sacdalan, Carlo   Sriplienchan, Somchai   Phanuphak, Nittaya   Chan, Phillip   Crowell, Trevor   Trautmann, Lydie   Vasan, Sandhya   Paul, Robert   Spudich, Serena   

              Session Name:S19: Navigating Neuroinfectious Diseases  

              Topic:Infectious Disease  

              Program Number:S19.005  

              Author Institution:University of Toronto, Toronto, ON, Canada  Yale University, New Haven, CT  

              Efficacy and Safety of Autologous BCMA-directed mRNA CAR T-Cell Therapy in Generalized Myasthenia Gravis: Results from a Phase 2b Randomized Placebo-controlled Trial

              Author:Vu, Tuan   Tekce, Hacer Durmus   Rivner, Michael   Shroff, Sheetal   Ragole, Thomas   Myers, Bennett   Pasnoor, Mamatha   Small, George   Karam, Chafic   Vullaganti, Mithila   Peltier, Amanda   Sahagian, Gregory   Feinberg, Marc   Barnett Tapia, Carolina   Siddiqi, Zaeem   Jewell, Chr   

              Session Name:S34: Updates on Myasthenia Gravis  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:S34.002  

              Author Institution:Augusta University, Augusta, GA  Houston Methodist Hospital, Houston, TX  University of Colorado Department of Neurology, Aurora, CO  Dent Neurologic Institute, Buffalo, NY  University of Kansas Medical Center, Kansas City, KS  ANA, Pittsburgh, PA  University of Pennsylvania, Philadelphia, PA  Tufts Medical Center, Boston, MA  Vanderbilt University, Nashville, TN  Neurology Center of Southern California, Carlsbad, CA  South Florida Neurology Ass., Boca Raton, FL  University of Toronto, Toronto, ON, Canada  University of Alberta Hospital, Edmonton, AB, Canada  Cartesian Therapeutics, Frederick, MD  Cartesian Therapeutics, Gaithersburg, MD  University of California Irvine, Orange, CA  

              AXS-12 for the Treatment of Narcolepsy: Topline Results from the Phase 3 SYMPHONY Trial

              Author:Thorpy, Michael   Krahn, Lois   Bogan, Richard   Corser, Bruce   Shapiro, Colin   Chhabra, Angad   Leary, Eileen   Tabuteau, Herriot   

              Session Name:PL5: Clinical Trials Plenary Session  

              Topic:Sleep  

              Program Number:PL5.007  

              Author Institution:Montefiore Medical Center, Bronx, NY  SleepMed, Columbia, SC  Intrepid Research, Cincinatti, OH  University of Toronto, Toronto, ON, Canada  Axsome Therapeutics, Inc., New York, NY  Axsome Therapeutics, Inc., San Francisco, CA  

              Evaluation of Measures for Ocular Manifestations in Myasthenia Gravis

              Author:Barnett Tapia, Carolina   Lawton, Catherine   Mendoza, Meg   Hamedani, Ali   Wolfe, Gil   Suh, Joome   Kupersmith, Mark   

              Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P1.002  

              Author Institution:University of Toronto, Toronto, ON, Canada